INTRODUCTION
Reports have shown that karyotyping a leukaemic cell population using conventional cytogenetic methods is one of the most important prognostic determinants in acute myeloid leukaemia (AML).' 2 closely associated with a distinct subtype of acute myelomonocytic leukaemia characterised by bone marrow eosinophilia. This subtype has been assigned the FAB-type M4Eo AMLs and although the eosinophilia can be variable it has been shown to be part of the leukaemia cell population.
Molecular studies have shown that these chromosome 16 abnormalities generate a fusion protein (CBF13-MYH I 1) between the core binding factor (CBFf3) gene at 16q22 and the smooth muscle myosin heavy chain (MYHi 1) gene at 16pl3 which plays a vital role in myeloid cell transformation leading to leukaemia. Despite such a transformation, it is still highly desirable to detect those M4Eo AML patients who possess such favourable chromosome 16 abnormalities. Conventional cytogenetic methods consisting of cell synchronisation and Giemsa banding (Gbanding) are currently used to detect chromosome 16 abnormalities but visualisation can often be difficult especially if metaphase preparations are of a poor quality. It is therefore likely that the frequency of these abnormalities is higher than reported 6 and individual patients unknowingly assigned to the wrong prognostic group and subsequent treatment strategy. The need for a more sensitive detection method as an adjunct to conventional cytogenetics at diagnosis is important for the correct stratification of such AML patients. In this retrospective study we have assessed a molecular technique known as fluorescence in situ hybridisation (FISH) using a dual colour CBFB DNA probe for the detection of chromosome 16 abnormalities and compared the results with our own conventional cytogenetic (G-banded) method and published data. probe (G) positioned telomeric to the 16q22 breakpoint. Hybridisation to a normal chromosome 16 homologue should therefore show a fused red/green signal (R/G) at the 16q22 region (Fig la) . Likewise, hybridisation to a chromosome 16 homologue containing an inv(16)(pl3q22) will cause this fused R/G signal to split with the individual red (R) and green (G) signals appearing on opposite arms of the inv(16) chromosome homologue (Fig la) . Hybridisation to chromosome 16 homologues involved in a t(16; 16) translocation preparation will result in a fused red/green signal (R/G) on the q arm at 16q22 on one chromosome 16 homologue and a green signal (G) on the p arm at 16pl3 while the second chromosome 16 homologue will only contain the red signal (R) on the q arm at 16q22 (Fig lb) .
MATERIALS AND METHODS

Statistical analysis
The outcome and survival of individual patients from the time of diagnosis was assessed in August 2001. Survival curves were estimated by the Kaplan-Meier method and compared M4Eo AML patients that were +ve by FISH for the typical 16q22 gene rearrangements (n=4) and the remaining M4Eo AML patients that were -ve by FISH for the typical 16q22 gene rearrangements (n=9) using the log-rank test. A P value <0.05 was considered statistically significant. All statistical computations were performed using SPSS for Windows (version 10).
RESULTS
Patient and cytogenetic/FISH data for the thirteen M4Eo AMI, patients are presented in Table 1 . 
